Top

Published in:

17-12-2022 | Parkinson's Disease | Original Article

Telerehabilitation during social distancing for people with Parkinson’s disease: a retrospective study

Authors: Erica Tardelli, Acácio Moreira-Neto, Erika Okamoto, Fernanda Rogatto, Mario Vergari-Filho, Egberto Reis Barbosa, Carla Silva-Batista

Published in: Acta Neurologica Belgica | Issue 4/2023

Abstract

Introduction/Aim

Clinical worsening has been common in people with Parkinson's disease (PD) during the social distancing due to pandemic. It is unclear if telerehabilitation applied during social distancing preserves clinical aspects of people with PD who are frequent exercisers before the pandemic. Thus, we compared the effects of 10 months of supervised, home-based, real-time videoconferencing telerehabilitation (SRTT) and nonexercising control on clinical aspects in people with PD who are frequent exercisers before the pandemic.

Methods

Fifty-seven (SRTT group) and 29 (nonexercising control group) people with PD were retrospectively assessed (Clinical Trials Registry: RBR-54sttfk). Only the SRTT group performed a 60-min online training sessions, 2–3 days per week, for 10 months (April 2020 to January 2021) during social distancing. Quality of life (PD Questionnaire [PDQ-39]), walking (item 28 from the Unified Parkinson’s Disease Rating Scale part III [UPDRS-III]), posture (item 29 from the UPDRS-III), and freezing of gait (New-FOG questionnaire [NFOGQ]) were retrospectively assessed before (February–March 2020) and during social distancing (February–March 2021). The assessments were performed in-person and remotely before and during social distancing, respectively.

Results

There were no between-group differences at baseline (p > 0.05). SRTT preserves PDQ-39 and walking scores but not posture and NFOGQ scores, while nonexercising control worsens scores in all variables. In addition, SRTT is more effective than nonexercising control in preserving PDQ-39 and walking scores.

Conclusion

During social distancing, long-term SRTT preserves the subjective quality of life and walking, but not subjective posture and FOG in people with PD who are frequent exercisers before the pandemic.

Available only for authorised users

Calbi M, Langiulli N, Ferroni F, Montalti M, Kolesnikov A, Gallese V et al (2021) The consequences of COVID-19 on social interactions: an online study on face covering. Sci Rep 11:2601. https://doi.org/10.1038/s41598-021-81780-wCrossRefPubMedPubMedCentral

Moreira-Neto A, Martins B, Miliatto A, Nucci MP, Silva-Batista C (2021) Can remotely supervised exercise positively affect self-reported depressive symptoms and physical activity levels during social distancing? Psychiatry Res 301:113969. https://doi.org/10.1016/j.psychres.2021.113969CrossRefPubMed

Coupet S, Nicolas G, Louder CN, Meyer M (2021) When public health messages become stressful: Managing chronic disease during COVID-19. Social Sciences & Humanities Open 4:100150. https://doi.org/10.1016/j.ssaho.2021.100150CrossRef

Antonini A, Leta V, Teo J, Chaudhuri KR (2020) Outcome of Parkinson’s disease patients affected by COVID-19. Movement Disorders: Official Journal of the Movement Disorder Society. https://doi.org/10.1002/mds.28104CrossRefPubMed

Silva-Batista C.; Coelho DB.; Junior RCF.; Almeida LR.; Guimaraes A.; Nobrega KCC, et al. (2021) Multidimensional factors can explain the clinical worsening in people with Parkinson's disease during the COVID-19 pandemic: a multicenter cross-sectional trial. Frontiers in Neurology 12: 708433. DOI: https://doi.org/10.3389/fneur.2021.708433.

Prasad S, Holla VV, Neeraja K, Surisetti BK, Kamble N, Yadav R et al (2020) Parkinson’s Disease and COVID-19: Perceptions and Implications in Patients and Caregivers. Movement disorders : official journal of the Movement Disorder Society. https://doi.org/10.1002/mds.28088CrossRefPubMed

Luis-Martinez R, Di Marco R, Weis L, Cianci V, Pistonesi F, Baba A et al (2021) Impact of social and mobility restrictions in Parkinson’s disease during COVID-19 lockdown. BMC Neurol 21:332. https://doi.org/10.1186/s12883-021-02364-9CrossRefPubMedPubMedCentral

Rodrigues-de-Paula F.; Lana RC.; Lopes LKR.; Cardoso F.; Lindquist ARR.; Piemonte MEP, et al. Determinants of the use of physiotherapy services among individuals with Parkinson's disease living in Brazil. Arquivos de neuro-psiquiatria. 2018, 76, 592–8. DOI: https://doi.org/10.1590/0004-282X20180087.

Langer A, Gassner L, Flotz A, Hasenauer S, Gruber J, Wizany L et al (2021) How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review. NPJ Parkinson’s disease 7:25. https://doi.org/10.1038/s41531-021-00160-3CrossRefPubMedPubMedCentral

10.

Gilat M, Ginis P, Zoetewei D, De Vleeschhauwer J, Hulzinga F, D’Cruz N et al (2021) A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s disease. NPJ Parkinson’s disease 7:81. https://doi.org/10.1038/s41531-021-00224-4CrossRefPubMedPubMedCentral

11.

Schenkman M, Cutson TM, Kuchibhatla M, Chandler J, Pieper CF, Ray L et al (1998) Exercise to improve spinal flexibility and function for people with Parkinson’s disease: a randomized, controlled trial. J Am Geriatr Soc 46:1207–1216. https://doi.org/10.1111/j.1532-5415.1998.tb04535.xCrossRefPubMed

12.

Tomlinson CL.; Patel S.; Meek C.; Herd CP.; Clarke CE.; Stowe R, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. The Cochrane database of systematic reviews. 2013, CD002817. DOI: https://doi.org/10.1002/14651858.CD002817.pub4.

13.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentral

14.

Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C et al (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Movement disorders : official journal of the Movement Disorder Society 19:1020–1028. https://doi.org/10.1002/mds.20213CrossRefPubMed

15.

Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T et al (2009) Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson’s disease and their carers. Gait Posture 30:459–463. https://doi.org/10.1016/j.gaitpost.2009.07.108CrossRefPubMed

16.

Brown MJ, Almeida QJ (2011) Evaluating dopaminergic system contributions to cued pattern switching during bimanual coordination. Eur J Neurosci 34:632–640. https://doi.org/10.1111/j.1460-9568.2011.07773.xCrossRefPubMed

17.

Fathipour-Azar Z, Azad A, Akbarfahimi M, Behzadipour S, Taghizadeh G (2022) Symmetric and asymmetric bimanual coordination and freezing of gait in Parkinsonian patients in drug phases. Ann N Y Acad Sci 1511:244–261. https://doi.org/10.1111/nyas.14759CrossRefPubMed

18.

Colosimo C, Merello M, Hughes AJ, Sieradzan K, Lees AJ (1996) Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson’s disease: implications for the pathogenesis of the on-off phenomenon. J Neurol Neurosurg Psychiatry 60:634–637. https://doi.org/10.1136/jnnp.60.6.634CrossRefPubMedPubMedCentral

19.

Silva-Batista C, Mattos EC, Corcos DM, Wilson JM, Heckman CJ, Kanegusuku H et al (1985) Resistance training with instability is more effective than resistance training in improving spinal inhibitory mechanisms in Parkinson’s disease. J Appl Physiol 2017(122):1–10. https://doi.org/10.1152/japplphysiol.00557.2016CrossRef

20.

Peto V, Jenkinson C, Fitzpatrick R (1998) PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures. J Neurol 245(Suppl 1):S10–S14. https://doi.org/10.1007/pl00007730CrossRefPubMed

21.

Fahn S.; Elton RL.; Members. UP. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson’s disease, Vol 2 Florham Park, NJ: Macmillan Healthcare Information. 1987, 153–63, 293–304. DOI: 959 [pii].

22.

Stillerova T, Liddle J, Gustafsson L, Lamont R, Silburn P (2016) Remotely Assessing Symptoms of Parkinson’s Disease Using Videoconferencing: A Feasibility Study. Neurol Res Int 2016:4802570. https://doi.org/10.1155/2016/4802570CrossRefPubMedPubMedCentral

23.

Fischer R, Bortolini T, Karl JA, Zilberberg M, Robinson K, Rabelo A et al (2020) Rapid Review and Meta-Meta-Analysis of Self-Guided Interventions to Address Anxiety, Depression, and Stress During COVID-19 Social Distancing. Front Psychol 11:563876. https://doi.org/10.3389/fpsyg.2020.563876CrossRefPubMedPubMedCentral

24.

Buckingham SA, Sein K, Anil K, Demain S, Gunn H, Jones RB et al (2022) Telerehabilitation for physical disabilities and movement impairment: A service evaluation in South West England. J Eval Clin Pract. https://doi.org/10.1111/jep.13689CrossRefPubMedPubMedCentral

25.

Lim SB, Horslen BC, Davis JR, Allum JH, Carpenter MG (2016) Benefits of multi-session balance and gait training with multi-modal biofeedback in healthy older adults. Gait Posture 47:10–17. https://doi.org/10.1016/j.gaitpost.2016.03.017CrossRefPubMed

26.

Rhea MR (2004) Determining the magnitude of treatment effects in strength training research through the use of the effect size. J Strength Cond Res 18:918–920. https://doi.org/10.1519/14403.1CrossRefPubMed

27.

Lixandrao ME, Ugrinowitsch C, Laurentino G, Libardi CA, Aihara AY, Cardoso FN et al (2015) Effects of exercise intensity and occlusion pressure after 12 weeks of resistance training with blood-flow restriction. Eur J Appl Physiol 115:2471–2480. https://doi.org/10.1007/s00421-015-3253-2CrossRefPubMed

28.

Nakagawa S, Cuthill IC (2007) Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc 82:591–605. https://doi.org/10.1111/j.1469-185X.2007.00027.xCrossRefPubMed

29.

Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale (NJ): L. Erlbaum Associates. Neurology. 1988, 29–35. DOI: https://doi.org/10.4324/9780203771587.

30.

Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement disorders : official journal of the Movement Disorder Society 25:2649–2653. https://doi.org/10.1002/mds.23429CrossRefPubMed

31.

Chen K, Tan Y, Lu Y, Wu J, Liu X, Zhao Y (2020) Effect of Exercise on Quality of Life in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Parkinson’s disease 2020:3257623. https://doi.org/10.1155/2020/3257623CrossRefPubMedPubMedCentral

32.

Siegert C, Hauptmann B, Jochems N, Schrader A, Deck R (2019) ParkProTrain: an individualized, tablet-based physiotherapy training programme aimed at improving quality of life and participation restrictions in PD patients - a study protocol for a quasi-randomized, longitudinal and sequential multi-method study. BMC Neurol 19:143. https://doi.org/10.1186/s12883-019-1355-xCrossRefPubMedPubMedCentral

33.

Isernia S, Di Tella S, Pagliari C, Jonsdottir J, Castiglioni C, Gindri P et al (2020) Effects of an Innovative Telerehabilitation Intervention for People With Parkinson’s Disease on Quality of Life, Motor, and Non-motor Abilities. Front Neurol 11:846. https://doi.org/10.3389/fneur.2020.00846CrossRefPubMedPubMedCentral

34.

O’Connor S, Hanlon P, O’Donnell CA, Garcia S, Glanville J, Mair FS (2016) Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Med Inform Decis Mak 16:120. https://doi.org/10.1186/s12911-016-0359-3CrossRefPubMedPubMedCentral

35.

Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson’s disease in the clinical phase: potential markers. The Lancet Neurology 8:1158–1171. https://doi.org/10.1016/S1474-4422(09)70291-1CrossRefPubMed

36.

Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA (2010) Predictors of future falls in Parkinson disease. Neurology 75:116–124. https://doi.org/10.1212/WNL.0b013e3181e7b688CrossRefPubMed

37.

Silva-Batista C, de Lima-Pardini AC, Nucci MP, Coelho DB, Batista A, Piemonte MEP et al (2020) A Randomized, Controlled Trial of Exercise for Parkinsonian Individuals With Freezing of Gait. Movement disorders : official journal of the Movement Disorder Society 35:1607–1617. https://doi.org/10.1002/mds.28128CrossRefPubMed

38.

Shen X, Wong-Yu IS, Mak MK (2016) Effects of Exercise on Falls, Balance, and Gait Ability in Parkinson’s Disease: A Meta-analysis. Neurorehabil Neural Repair 30:512–527. https://doi.org/10.1177/1545968315613447CrossRefPubMed

39.

Ellis T, Boudreau JK, DeAngelis TR, Brown LE, Cavanaugh JT, Earhart GM et al (2013) Barriers to exercise in people with Parkinson disease. Phys Ther 93:628–636. https://doi.org/10.2522/ptj.20120279CrossRefPubMedPubMedCentral

40.

Gandolfi M, Geroin C, Dimitrova E, Boldrini P, Waldner A, Bonadiman S et al (2017) Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized. Controlled Trial BioMed Research International 2017:7962826. https://doi.org/10.1155/2017/7962826CrossRefPubMed

41.

Cramer SC, Dodakian L, Le V, See J, Augsburger R, McKenzie A et al (2019) Efficacy of Home-Based Telerehabilitation vs In-Clinic Therapy for Adults After Stroke: A Randomized Clinical Trial. JAMA Neurol 76:1079–1087. https://doi.org/10.1001/jamaneurol.2019.1604CrossRefPubMedPubMedCentral

Title: Telerehabilitation during social distancing for people with Parkinson’s disease: a retrospective study
Authors: Erica Tardelli
Acácio Moreira-Neto
Erika Okamoto
Fernanda Rogatto
Mario Vergari-Filho
Egberto Reis Barbosa
Carla Silva-Batista
Publication date: 17-12-2022
Publisher: Springer International Publishing
Keyword: Parkinson's Disease
Published in: Acta Neurologica Belgica / Issue 4/2023
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-022-02160-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Telerehabilitation during social distancing for people with Parkinson’s disease: a retrospective study

Abstract

Introduction/Aim

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction/Aim

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2023

Female migraine patients had lower COVID-19 phobia and PCL-5 scores during the lockdown period

Neuronal intranuclear inclusion disease: a case report and literature review

Migraine and its association with pubertal maturation and behavioral traits among adolescent girls

Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson’s disease

Validity, reliability and minimal detectable change of Mini-BESTest Turkish version in neurological disorders

Plus minus lid syndrome in Myasthenia gravis